Keith Dredge
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Cell Biology top 1%
- Proteoglycans and glycosaminoglycans research
Papers in
-
- Angiogenesis and VEGF in Cancer 11
- Fibroblast Growth Factor Research 10
- Glycosylation and Glycoproteins Research 8
- Protein Degradation and Inhibitors 8
- Cell Biology 19
- Proteoglycans and glycosaminoglycans research 17
- Co-authors
- Angus Dalgleish (15 shared papers)J. Blake Bartlett (6 shared papers)Edward Hammond (23 shared papers)George W. Muller (9 shared papers)David Stirling (8 shared papers)J B Marriott (7 shared papers)Stephen Todryk (3 shared papers)Ian Bytheway (10 shared papers)
- Journals
- Molecular Cancer Therapeutics (4 papers)British Journal of Cancer (4 papers)Blood (2 papers)Cancer Immunology Immunotherapy (2 papers)Oncotarget (2 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Keith Dredge
55 papers receiving 3.7k citations
Keith Dredge's Hit Papers
Peers
Comparison fields: 5 of 112
- Hematology 1.2k
- Cell Biology 916
- Oncology 812
- Genetics 316
- Molecular Biology 2.0k
Countries citing papers authored by Keith Dredge
This map shows the geographic impact of Keith Dredge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Dredge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Dredge more than expected).
Fields of papers citing papers by Keith Dredge
This network shows the impact of papers produced by Keith Dredge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Dredge. The network helps show where Keith Dredge may publish in the future.
Co-authors
The 25 scholars most cited alongside Keith Dredge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The evolution of thalidomide and its IMiD derivatives as anticancer agents Hit paper breakdown → | 2004 | 637 |
| 2 | 2008 | 327 | |
| 3 | 2002 | 255 | |
| 4 | 2005 | 225 | |
| 5 | 2011 | 147 | |
| 6 | 2014 | 147 | |
| 7 | 2002 | 143 | |
| 8 | 2002 | 127 | |
| 9 | 2007 | 124 | |
| 10 | 2004 | 123 | |
| 11 | 2012 | 108 | |
| 12 | 2002 | 105 | |
| 13 | 2009 | 95 | |
| 14 | 2012 | 92 | |
| 15 | 1999 | 79 | |
| 16 | 2018 | 76 | |
| 17 | 2010 | 64 | |
| 18 | 2013 | 61 | |
| 19 | 2015 | 58 | |
| 20 | 2012 | 57 |
About Keith Dredge
Keith Dredge is a scholar working on Molecular Biology, Cell Biology, Hematology, Immunology and Oncology, having authored 55 papers that have together received 3.7k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (17 papers), Multiple Myeloma Research and Treatments (13 papers), Angiogenesis and VEGF in Cancer (11 papers), Fibroblast Growth Factor Research (10 papers), Glycosylation and Glycoproteins Research (8 papers), Protein Degradation and Inhibitors (8 papers), Immunotherapy and Immune Responses (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Hematology (1.2k citations), Cell Biology (916 citations), Oncology (812 citations), Genetics (316 citations) and Molecular Biology (2.0k citations). Keith Dredge has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Angus Dalgleish, J. Blake Bartlett, Edward Hammond, George W. Muller, David Stirling, J B Marriott, Stephen Todryk, Ian Bytheway, Viji Shridhar and Peter Schäfer. Their work appears in journals such as Molecular Cancer Therapeutics, British Journal of Cancer, Blood, Cancer Immunology Immunotherapy and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.